Yes, Beloc is often combined with other antihypertensives such as ACE inhibitors, diuretics, or calcium-channel blockers. However, dose adjustments may be required to avoid excessive blood pressure reduction. Your prescriber will tailor the regimen to your individual needs.
Mild fatigue is a common early side effect. If it persists beyond a week or interferes with daily activities, contact your healthcare provider; a dose reduction or slower titration may be recommended.
Metoprolol is β₁-selective, which reduces but does not eliminate the risk of bronchospasm. Patients with mild asthma may use it cautiously, while those with severe disease should avoid it or select a more cardio-selective agent under medical supervision.
Blood pressure often begins to fall within 1-2 hours after the first dose, with the full effect typically observed after 2-4 weeks of consistent therapy.
Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of any import restrictions for prescription drugs in the destination country.
Consistent timing helps maintain stable drug levels. Taking Beloc with breakfast and dinner (or as directed) is advisable, especially for twice-daily regimens.
Grapefruit can inhibit CYP2D6 metabolism, potentially raising metoprolol concentrations. Moderate consumption is unlikely to cause major issues, but regular large amounts should be discussed with your clinician.
Metoprolol tartrate is marketed under various brand names worldwide, and generic versions are widely available. In Hong Kong, the formulation may be dispensed as a generic tablet if prescribed.
Seek immediate medical attention if you experience severe dizziness, fainting, very slow heart rate (< 40 beats/min), marked shortness of breath, or swelling of the face/lips, which may indicate an allergic reaction or life-threatening bradycardia.
Beloc is a prescription-only pill that contains metoprolol tartrate as its active ingredient. It belongs to the therapeutic class Heart & Blood Pressure medicines and is commonly used to manage conditions related to cardiac workload and arterial pressure. In Hong Kong, Beloc is regulated under the Pharmaceutical Service Division of the Department of Health and may only be dispensed with a valid medical prescription. The medication is supplied in 20 mg and 40 mg tablet strengths.
Metoprolol tartrate, the active component of Beloc, is a β₁-selective adrenergic blocker. By selectively antagonising β₁ receptors in the heart, it reduces heart rate, myocardial contractility, and the force of conduction through the atrioventricular node. These actions help lower blood pressure, relieve angina, and stabilise abnormal heart rhythms.
Metoprolol tartrate exerts its therapeutic effect through several well-studied mechanisms:
Metoprolol tartrate is rapidly absorbed after oral administration, with peak plasma concentrations reached within 1-2 hours. It undergoes extensive first-pass metabolism in the liver, primarily via the CYP2D6 enzyme, and is excreted unchanged in the urine.
Beloc is approved in Hong Kong for the following indications, consistent with international regulatory guidance:
These uses are supported by clinical trials and guideline recommendations from bodies such as the American College of Cardiology/American Heart Association (ACC/AHA) and the European Society of Cardiology (ESC), which are also referenced by Hong Kong clinicians.
While not formally approved for these indications, peer-reviewed studies have explored additional applications of metoprolol tartrate:
Disclaimer: Off-label use of Beloc requires supervision by a qualified healthcare professional and should be based on a careful risk-benefit assessment.
Major Interactions
Other β-blockers - Additive negative chronotropic effects; concurrent use generally avoided.
Calcium-channel blockers (verapamil, diltiazem) - May cause profound bradycardia or AV block.
Anti-arrhythmic agents (e.g., amiodarone, quinidine) - Increased risk of conduction disturbances.
Moderate Interactions
CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine) - May raise plasma metoprolol levels, requiring dose reduction.
Insulin or oral hypoglycaemic agents - β-blockade can mask hypoglycaemia; monitor blood glucose closely.
Non-steroidal anti-inflammatory drugs (NSAIDs) - May reduce antihypertensive efficacy.
Food and Lifestyle Interactions
Alcohol - Can enhance hypotensive effects; moderate consumption is advised.
Grapefruit juice - May inhibit CYP2D6, modestly increasing metoprolol exposure.
Driving or operating machinery - Patients should assess how the medication affects alertness, especially during dose titration.
General Advice: Inform your pharmacist or prescriber of all medicines, supplements, and herbal products before starting Beloc.
Patients should promptly contact their healthcare provider if they experience persistent dizziness, fainting, severe fatigue, or any new cardiac symptoms.
This article provides educational information about Beloc and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
